List of Desyrel drug patents

Desyrel is owned by Pragma.

Desyrel contains Trazodone Hydrochloride.

Desyrel has a total of 1 drug patent out of which 0 drug patents have expired.

Desyrel was authorised for market use on 25 March, 1985.

Desyrel is available in tablet;oral dosage forms.

The generics of Desyrel are possible to be released after 13 March, 2029.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8133893 PRAGMA Trazodone and trazodone hydrochloride in purified form
Mar, 2029

(6 years from now)

Drugs and Companies using TRAZODONE HYDROCHLORIDE ingredient

Market Authorisation Date: 25 March, 1985

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of DESYREL before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in